tm logo

Monitor this mark

View On USPTO

RYZUMVI
Live/Registered
REGISTERED

on 26 Nov 2024

Last Applicant/ Owned by

OCUPHIRE PHARMA, INC.

37000 Grand River Avenue, Suite 120

Farmington Hills

MI

48335

Serial Number

97979106 filed on 10th Oct 2022

Registration Number

7581889 registered on 26th Nov 2024

in the Principal Register

Correspondent Address

Glenn A. Gundersen

Glenn A. Gundersen DECHERT LLP

CIRA CENTRE

PHILADELPHIA, PA 19104

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

RYZUMVI

PHARMACEUTICAL PRODUCTS FOR OPHTHALMOLOGICAL USE; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES AND CONDITIONS

Classification Information

Class [005]
Pharmaceutical Products

PHARMACEUTICAL PRODUCTS FOR OPHTHALMOLOGICAL USE; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES AND CONDITIONS

First Use Date in General

01st Apr 2024

First Use Date in Commerce

01st Apr 2024

Mark Details

Serial Number

No 97979106

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
26th Nov 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
26th Nov 2024REGISTERED-PRINCIPAL REGISTER
05th Nov 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05th Nov 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
23rd Oct 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
23rd Oct 2024DIVISIONAL PROCESSING COMPLETE
23rd Oct 2024STATEMENT OF USE PROCESSING COMPLETE
07th May 2024TEAS REQUEST TO DIVIDE RECEIVED
07th May 2024DIVISIONAL REQUEST RECEIVED
07th May 2024USE AMENDMENT FILED